Clinician-guided peptide care

A measured approach to hormone support.

A clinician-guided injectable peptide pathway with provider-determined laboratory review, dosing, and monitoring.

Compounded sermorelin injection vial
01 · FormatSubcutaneous injection
02 · PathwayGHRH analog
03 · CadenceProvider selected
04 · Supply28-day or 90-day injection supply

Understand the path

Clinical context.
Real-life rhythm.

Sermorelin is a 29-amino-acid growth hormone-releasing hormone (GHRH) analog. It acts through the pituitary gland to stimulate the body’s own growth-hormone release rather than supplying synthetic human growth hormone. Eligibility, testing, dose, and monitoring are provider determined.

Mature adult completing a gentle morning mobility routine
Designed for real life · Individual results vary
01

Pituitary signaling

Acts upstream through the pituitary gland rather than introducing synthetic human growth hormone.

02

Clinical review

A provider reviews relevant health history and determines which laboratory tests, including IGF-1 when appropriate, are needed.

03

Individual instructions

Route, dose, timing, storage, and monitoring must follow the prescriber and dispensing pharmacy’s directions.

Published pricing

Know the range.

Final treatment, strength, supply, and price depend on provider approval. Published prices may change.

01
28-day plan15 mg supply
  • 15 mg / 28 days$250

Consultation and discreet delivery included

02
90-day planBilled as a three-month supply
  • 45 mg / 90 days$600

Consultation and discreet delivery included

Possible effects
  • Injection-site redness, swelling, pain, or itching
  • Flushing, headache, dizziness, or nausea
  • Fluid retention or joint discomfort
  • Unexpected or persistent symptoms should be reported promptly
Screening considerations
  • Relevant laboratory review, as provider directed
  • History of active malignancy or intracranial lesions
  • Known allergy to sermorelin or formulation ingredients
  • Current health conditions, prescriptions, and supplements
How is sermorelin different from synthetic HGH?

Sermorelin signals the pituitary gland to release growth hormone. It does not introduce synthetic human growth hormone. A provider determines whether any hormone-related pathway is appropriate.

How is injectable sermorelin administered?

When prescribed as an injection, sermorelin is administered subcutaneously. Use only the injection site, timing, dose, and technique supplied by your prescriber and dispensing pharmacy.

How should injectable sermorelin be stored?

Storage and beyond-use dates depend on the dispensed formulation. Follow the pharmacy label exactly; reconstituted medication commonly requires refrigeration. Do not use medication beyond the pharmacy’s stated date.

Are labs required?

Your provider determines which tests are needed, which may include IGF-1 and other clinically relevant laboratory work, and reviews them before or during treatment.

What results should I expect?

Individual response varies. Changes in sleep, recovery, body composition, energy, metabolism, skin, bone density, or other outcomes are not guaranteed.

Compounded medications require a valid prescription and are not reviewed or approved by the FDA as finished drug products for safety, effectiveness, or quality. Body Forward coordinates care and does not manufacture medication.